BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22395072)

  • 1. Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor.
    López-Sagaseta J; Sibener LV; Kung JE; Gumperz J; Adams EJ
    EMBO J; 2012 Apr; 31(8):2047-59. PubMed ID: 22395072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors.
    Guo T; Chamoto K; Nakatsugawa M; Ochi T; Yamashita Y; Anczurowski M; Butler MO; Hirano N
    PLoS One; 2016; 11(5):e0156114. PubMed ID: 27213277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
    Lawson V
    Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.
    López-Sagaseta J; Kung JE; Savage PB; Gumperz J; Adams EJ
    PLoS Biol; 2012; 10(10):e1001412. PubMed ID: 23109910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural variations at position 93 of the invariant Vα24-Jα18 α chain of human iNKT-cell TCRs strongly impact on CD1d binding.
    Sanderson JP; Waldburger-Hauri K; Garzón D; Matulis G; Mansour S; Pumphrey NJ; Lissin N; Villiger PM; Jakobsen B; Faraldo-Gómez JD; Gadola SD
    Eur J Immunol; 2012 Jan; 42(1):248-55. PubMed ID: 21956730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex.
    Wun KS; Ross F; Patel O; Besra GS; Porcelli SA; Richardson SK; Keshipeddy S; Howell AR; Godfrey DI; Rossjohn J
    J Biol Chem; 2012 Nov; 287(46):39139-48. PubMed ID: 22995911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD1d protein structure determines species-selective antigenicity of isoglobotrihexosylceramide (iGb3) to invariant NKT cells.
    Sanderson JP; Brennan PJ; Mansour S; Matulis G; Patel O; Lissin N; Godfrey DI; Kawahara K; Zähringer U; Rossjohn J; Brenner MB; Gadola SD
    Eur J Immunol; 2013 Mar; 43(3):815-25. PubMed ID: 23280365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
    Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
    Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.
    Matulis G; Sanderson JP; Lissin NM; Asparuhova MB; Bommineni GR; Schümperli D; Schmidt RR; Villiger PM; Jakobsen BK; Gadola SD
    PLoS Biol; 2010 Jun; 8(6):e1000402. PubMed ID: 20585371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique interplay between sugar and lipid in determining the antigenic potency of bacterial antigens for NKT cells.
    Girardi E; Yu ED; Li Y; Tarumoto N; Pei B; Wang J; Illarionov P; Kinjo Y; Kronenberg M; Zajonc DM
    PLoS Biol; 2011 Nov; 9(11):e1001189. PubMed ID: 22069376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.
    Yu ED; Girardi E; Wang J; Mac TT; Yu KO; Van Calenbergh S; Porcelli SA; Zajonc DM
    J Biol Chem; 2012 Jan; 287(2):1269-78. PubMed ID: 22110136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire.
    Mallevaey T; Scott-Browne JP; Matsuda JL; Young MH; Pellicci DG; Patel O; Thakur M; Kjer-Nielsen L; Richardson SK; Cerundolo V; Howell AR; McCluskey J; Godfrey DI; Rossjohn J; Marrack P; Gapin L
    Immunity; 2009 Jul; 31(1):60-71. PubMed ID: 19592274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypervariable region 4 (HV4) and position 93 of the α chain modulate CD1d-glycolipid binding of iNKT TCRs.
    Paletta D; Fichtner AS; Hahn AM; Starick L; Beyersdorf N; Monzon-Casanova E; Mueller TD; Herrmann T
    Eur J Immunol; 2015 Jul; 45(7):2122-33. PubMed ID: 25900449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
    Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
    Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
    Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
    Maricic I; Girardi E; Zajonc DM; Kumar V
    J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD1d-independent activation of invariant natural killer T cells by staphylococcal enterotoxin B through major histocompatibility complex class II/T cell receptor interaction results in acute lung injury.
    Rieder SA; Nagarkatti P; Nagarkatti M
    Infect Immun; 2011 Aug; 79(8):3141-8. PubMed ID: 21628519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
    Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
    BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDR3β sequence motifs regulate autoreactivity of human invariant NKT cell receptors.
    Chamoto K; Guo T; Imataki O; Tanaka M; Nakatsugawa M; Ochi T; Yamashita Y; Saito AM; Saito TI; Butler MO; Hirano N
    J Autoimmun; 2016 Apr; 68():39-51. PubMed ID: 26748722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.